153 related articles for article (PubMed ID: 7288869)
1. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
Wyatt RJ; Bridges RB; Halatek DG
J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
[TBL] [Abstract][Full Text] [Related]
2. The effect of aging on complement activity (CH50) and complement protein levels.
Nagaki K; Hiramatsu S; Inai S; Sasaki A
J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
[TBL] [Abstract][Full Text] [Related]
3. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
4. Serum complement profile in human leprosy and its comparison with immune complex diseases.
Saha K; Chakraborty AK
Int J Lepr Other Mycobact Dis; 1977; 45(4):327-37. PubMed ID: 147246
[TBL] [Abstract][Full Text] [Related]
5. [Serum complement composition of myasthenia gravis].
Hao ZS
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):141-3, 190. PubMed ID: 2591267
[TBL] [Abstract][Full Text] [Related]
6. Haemolytic complement in peripheral lymph of normal men.
Olszewski WL; Engeset A
Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278
[TBL] [Abstract][Full Text] [Related]
7. Testing of hemolytic complement components in domestic animals.
Barta O; Hubbert NL
Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
[TBL] [Abstract][Full Text] [Related]
8. Hypochlorite-induced alterations to canine serum complement.
Boyer JT; Wyde P; Bier M
Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
Kitamura H; Tsuboi M
Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary complement deficiencies].
Fischer E
Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
[TBL] [Abstract][Full Text] [Related]
11. The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.
Mak LW
Clin Exp Immunol; 1978 Mar; 31(3):419-25. PubMed ID: 657587
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma.
Lichtenfeld JL; Wiernik PH; Mardiney MR; Zarco RM
Cancer Res; 1976 Oct; 36(10):3678-80. PubMed ID: 953991
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of C6, C7, C9 and C1-INH analysis].
Akagaki Y; Inai S
Nihon Rinsho; 1990 Feb; 48 Suppl():662-5. PubMed ID: 2113138
[No Abstract] [Full Text] [Related]
14. Complement inhibitors in normal cornea and aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):483-6. PubMed ID: 6706511
[TBL] [Abstract][Full Text] [Related]
15. Immunological studies of human placentae: complement components in immature and mature chorionic villi.
Faulk WP; Jarret R; Keane M; Johnson PM; Boackle RJ
Clin Exp Immunol; 1980 May; 40(2):299-305. PubMed ID: 7002386
[TBL] [Abstract][Full Text] [Related]
16. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.
Ballow M; Fang F; Good RA; Day NK
Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765
[TBL] [Abstract][Full Text] [Related]
17. C1 inactivator and C3b inactivator in peripheral lymph of normal men.
Olszewski WL; Lukomska B; Engeset A
Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):79-86. PubMed ID: 7149928
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma concentrations of C9, C1-inhibitor and alpha 1-protease inhibitor associated with cigarette smoking.
Bridges RB; Rehm SR; Wyatt RJ
Life Sci; 1985 Mar; 36(10):955-63. PubMed ID: 3871890
[TBL] [Abstract][Full Text] [Related]
20. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
